Ulrike Protzer

22.6k total citations · 2 hit papers
300 papers, 10.2k citations indexed

About

Ulrike Protzer is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Ulrike Protzer has authored 300 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Epidemiology, 126 papers in Hepatology and 90 papers in Immunology. Recurrent topics in Ulrike Protzer's work include Hepatitis B Virus Studies (176 papers), Hepatitis C virus research (111 papers) and Immunotherapy and Immune Responses (54 papers). Ulrike Protzer is often cited by papers focused on Hepatitis B Virus Studies (176 papers), Hepatitis C virus research (111 papers) and Immunotherapy and Immune Responses (54 papers). Ulrike Protzer collaborates with scholars based in Germany, United States and France. Ulrike Protzer's co-authors include Percy A. Knolle, Julie Lucifora, Maria Quasdorff, Mala K. Maini, Jane A. McKeating, Silke Arzberger, Mathias Heikenwälder, Knud Esser, Yuchen Xia and Marianna Hösel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ulrike Protzer

285 papers receiving 10.1k citations

Hit Papers

Living in the liver: hepa... 2012 2026 2016 2021 2012 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Living in the liver: hepatic infections
    2012 417 citations Ulrike Protzer, Percy A. Knolle et al. profile →
  2. Viral hepatitis and liver cancer
    2017 277 citations Jane A. McKeating, Ulrike Protzer et al. Philosophical Transactions of the Royal Society B Biological Sciences profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ulrike Protzer 6.4k 4.6k 2.6k 2.4k 1.7k 300 10.2k
T. Jake Liang 9.1k 1.4× 8.9k 1.9× 1.7k 0.7× 2.3k 0.9× 1.6k 0.9× 195 13.2k
Kui Li 4.3k 0.7× 4.0k 0.9× 4.7k 1.8× 2.9k 1.2× 2.3k 1.3× 139 11.2k
Luca G. Guidotti 8.8k 1.4× 6.6k 1.4× 5.5k 2.1× 1.9k 0.8× 1.8k 1.0× 111 13.8k
Mengji Lu 5.3k 0.8× 3.6k 0.8× 2.5k 1.0× 2.2k 0.9× 2.6k 1.5× 319 9.7k
Mala K. Maini 6.4k 1.0× 4.9k 1.1× 5.3k 2.0× 1.2k 0.5× 1.4k 0.8× 130 11.2k
Nobuyuki Kato 6.0k 0.9× 7.2k 1.6× 1.5k 0.6× 2.9k 1.2× 1.3k 0.8× 223 11.3k
Darius Moradpour 7.4k 1.2× 10.4k 2.3× 3.0k 1.2× 3.6k 1.5× 2.4k 1.4× 273 15.4k
Thomas F. Baumert 7.9k 1.2× 8.4k 1.8× 1.8k 0.7× 3.2k 1.4× 1.3k 0.8× 273 13.9k
Sergio Abrignani 4.6k 0.7× 5.3k 1.1× 4.7k 1.8× 2.6k 1.1× 1.2k 0.7× 175 12.7k
Geert Leroux‐Roels 6.9k 1.1× 4.6k 1.0× 3.0k 1.2× 1.8k 0.8× 2.2k 1.3× 297 11.5k

Countries citing papers authored by Ulrike Protzer

Since Specialization
Citations

This map shows the geographic impact of Ulrike Protzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Protzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Protzer more than expected).

Fields of papers citing papers by Ulrike Protzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Protzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Protzer. The network helps show where Ulrike Protzer may publish in the future.

Co-authorship network of co-authors of Ulrike Protzer

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Protzer. A scholar is included among the top collaborators of Ulrike Protzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Protzer. Ulrike Protzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wettengel, Jochen M., Hiroaki Naka, Gregory A. Dissen, et al.. (2024). High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5. Vaccines. 12(2). 155–155. 3 indexed citations
3.
4.
Cheng, Cho‐Chin, Catharina Christa, Bernhard Haller, et al.. (2024). SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine. Vaccines. 12(3). 308–308. 3 indexed citations
5.
Allweiss, Lena, Barbara Testoni, Yu Mei, et al.. (2023). Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 72(5). 972–983. 43 indexed citations
6.
Tergast, Tammo Lambert, Ulrike Protzer, Stefan Zeuzem, et al.. (2023). Strategietreffen: Virushepatitis in Deutschland eliminieren – Was ist zu tun?. Zeitschrift für Gastroenterologie. 61(2). 198–201.
7.
Su, Jinpeng, Anna D. Kosinska, Pavlo Bielytskyi, et al.. (2023). Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component. JHEP Reports. 6(4). 100997–100997. 2 indexed citations
8.
Su, Jinpeng, Livia Brunner, Frank Thiele, et al.. (2023). Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. Journal of Hepatology. 78(4). 717–730. 34 indexed citations
9.
Kohantorabi, Mona, Michael Wagstaffe, Tobias Krekeler, et al.. (2023). Adsorption and Inactivation of SARS-CoV-2 on the Surface of Anatase TiO2(101). ACS Applied Materials & Interfaces. 15(6). 8770–8782. 7 indexed citations
10.
11.
Kosinska, Anna D., Kristina Kemter, Lisa Wolff, et al.. (2022). Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance. JHEP Reports. 5(2). 100603–100603. 5 indexed citations
12.
Maurer, H. Carlo, David Schult, Sandra Reitmeier, et al.. (2022). Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi. 8(12). 1265–1265.
13.
Schult, David, Sandra Reitmeier, Tobias Lahmer, et al.. (2022). Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 14(1). 2031840–2031840. 59 indexed citations
14.
Zhao, Lili, Marc Ringelhan, Karin Wisskirchen, et al.. (2021). Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane. Cellular Microbiology. 23(12). e13399–e13399. 6 indexed citations
15.
Osterman, Andreas, Marcel Stern, Maximilian Muenchhoff, et al.. (2021). Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Medical Microbiology and Immunology. 210(5-6). 263–275. 40 indexed citations
16.
Wettengel, Jochen M., et al.. (2021). Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications. Viruses. 13(8). 1503–1503. 16 indexed citations
17.
Ganesan, Murali, Weimin Wang, Saumi Mathews, et al.. (2021). Ethanol attenuates presentation of cytotoxic T‐lymphocyte epitopes on hepatocytes of HBV‐infected humanized mice. Alcoholism Clinical and Experimental Research. 46(1). 40–51. 7 indexed citations
18.
Burian, Egon, Friederike Jungmann, Georgios Kaissis, et al.. (2020). Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort. Journal of Clinical Medicine. 9(5). 1514–1514. 48 indexed citations
19.
McKeating, Jane A., et al.. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B Biological Sciences. 372(1732). 20160274–20160274. 277 indexed citations breakdown →
20.
Thiele, Frank, Sha Tao, Yi Zhang, et al.. (2014). Modified Vaccinia Virus Ankara-Infected Dendritic Cells Present CD4 + T-Cell Epitopes by Endogenous Major Histocompatibility Complex Class II Presentation Pathways. Journal of Virology. 89(5). 2698–2709. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Jake Liang Breakdown of academic impact, for papers by Kui Li Breakdown of academic impact, for papers by Luca G. Guidotti Breakdown of academic impact, for papers by Mengji Lu Breakdown of academic impact, for papers by Mala K. Maini Breakdown of academic impact, for papers by Nobuyuki Kato Breakdown of academic impact, for papers by Darius Moradpour Breakdown of academic impact, for papers by Thomas F. Baumert Breakdown of academic impact, for papers by Sergio Abrignani Breakdown of academic impact, for papers by Geert Leroux‐Roels
Rankless by CCL
2026